Dechra announces U.S. launch of Solovecin™ (cefovecin sodium), an in-clinic antibiotic solution for skin infections in dogs and cats
Dechra, the global leader in veterinary specialty care, is proud to announce the U.S. launch of Solovecin™ (cefovecin sodium), a long-acting injectable antibiotic for the treatment of skin infections in dogs and cats — the top reason veterinarians prescribe antibiotics.1 With skin infections affecting 10-15% of the canine population and up to 20% of the feline population, Solovecin gives veterinarians an affordable tool to extend quality care to more patients, including cats and larger dogs.2,3,4
